Associate Director, Portfolio Intelligence

BridgeBio
Palo Alto, San Francisco
Workplace: HybridFull timeUSD 210,000 - 232,900 annuallyFunction: Executive & General ManagementExperience: 3+ yearsEducation: bachelorsSkills: ["Problem-solving","Communication","Collaboration","Analytical thinking","Attention to detail"]

Analytical, cross-functional role at the intersection of science, strategy, and finance. Owns independent views on the value, risks, and performance of BridgeBio’s portfolio, translating complex scientific and financial analyses into clear recommendations for executive leadership and the Board. Combines portfolio economics with market, competitive, and regulatory insights to inform strategic asset decisions in a fast-paced, hybrid work environment.

Loading

Loading job details...

Preparing the role view and application actions.

FursaFursa
BridgeBio
BridgeBio
3 months ago

Associate Director, Portfolio Intelligence

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI
Last checked: 7 hours agoStatus: Live

Job Summary

Analytical, cross-functional role at the intersection of science, strategy, and finance. Owns independent views on the value, risks, and performance of BridgeBio’s portfolio, translating complex scientific and financial analyses into clear recommendations for executive leadership and the Board. Combines portfolio economics with market, competitive, and regulatory insights to inform strategic asset decisions in a fast-paced, hybrid work environment.
Location: Palo Alto, San Francisco
Workplace: Hybrid
Employment Type: Full time
Job Function: Executive & General Management
Seniority: Director level

Key Responsibilities

  • •Commercial Analytics & Forecasting: Develop independent, analytically rigorous views on commercial performance of BridgeBio’s assets, including launch performance, market opportunity, competitive positioning, and revenue potential.
  • •Performance Benchmarking: Track commercial performance against internal plans, Street expectations, peer launches, and other relevant analogues to identify key drivers of over- or under-performance.
  • •Market & Competitive Intelligence: Monitor market, competitive, regulatory, clinical, and investor developments that may affect asset value, launch trajectory, strategic positioning, or investor perception.
  • •Executive & Board Support: Synthesize complex commercial and financial analyses into clear recommendations for senior leadership, the Board, and other key stakeholders, including materials supporting earnings, Board meetings, investor questions, and major portfolio decisions.
  • •Portfolio Decision Support: Partner internal teams to evaluate key portfolio decisions through scenario modeling, valuation, risk assessment, and assessment of strategic options.

Pay and Benefits

Salary: USD 210,000 - 232,900 annually
Equity and Bonus:Equity
Perks:Health Insurance401kEsppEquityPaid Leave

Key Requirements

  • •Bachelor’s degree in science, engineering, business, finance, economics, or a related analytical discipline; advanced degree strongly preferred
  • •3+ years of experience in commercial analytics, with prior experience in management consulting, investment banking, or healthcare investing (VC/PE) preferred
  • •Deep fluency in financial modeling and valuation; experience with real options analysis, Monte Carlo simulation, or other quantitative frameworks is highly preferred
  • •Excellent problem-solving ability, first-principles approach to complex questions, and ability to translate analyses into clear, actionable recommendations
  • •Familiarity with industry data platforms like IQVIA or Komodo and financial data platforms like Bloomberg or Capital IQ
Experience:3+ yearsBiotechPharmaHealthcareLife sciences
Education:Bachelor's
Skills:Problem-solvingCommunicationCollaborationAnalytical thinkingAttention to detail
Languages:English
Tech Stack:IQVIAKomodoBloombergCapital IQ

Company Brief

BridgeBio
Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.
Industry: Biotech
Company Size: Large (251 to 1,000 employees)
Growth: Public Company
Valuation: Public Company (Market Cap in USD)
Funding: IPO / Publicly Listed
Headquarters: Palo Alto, United States
Founded: 2015
WebsiteLinkedIn